Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer
Harsimar Kaur, Thiago Vidotto, Adrianna A. Mendes, Daniela C. Salles, William B. Isaacs, Emmanuel S. Antonarakis, Tamara L. Lotan
Topics & Concepts
Prostate cancerTumor-infiltrating lymphocytesFOXP3GermlineGermline mutationProstateCancer researchBiologyCD8OncologyCancerInternal medicineMedicineMutationImmunotherapyImmunologyGeneImmune systemGeneticsCancer Immunotherapy and BiomarkersProstate Cancer Treatment and ResearchPARP inhibition in cancer therapy